The Pharmacy Times® Psychedelics Resource Center is a comprehensive resource for clinical news and expert insights on issues related to psychedelic medicine, which includes drugs such as psilocybin, MDMA, LSD, and ketamine, among others. Although not commonly identified as a psychedelic medicine, cannabis can also be included in this category.
March 12th 2025
The health care community was left largely unaware of the controversy that occurred at one of the clinical trial sites.
Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
October 4th 2024When considering the 3-stage framework, perhaps a greater emphasis on pre-treatment phase research could help identify some of the more individual traits used to better predict patient outcomes.
Read More
From Opioids to Cannabis: The Impact of Cannabis Rescheduling on Pharmacy Revenue Streams
September 11th 2024The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment for pharmacies and their involvement in the cannabis market.
Read More
Navigating the Psychedelic Renaissance: Emerging Mental Health Therapies and the Pharmacist’s Role
March 27th 2024Psychedelic medicines such as psilocybin, MDMA, ketamine, and LSD have been shown to have a significant impact on conditions such as major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder in clinical trials.
Read More
Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders
December 11th 2023By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
Read More
Psychedelic Research May Support Unprecedented End-of-Life Care for Patients With Cancer
June 1st 2023Psilocybin and other psychedelics hold promise in treating anxiety, depression, substance abuse and addiction, posttraumatic stress disorder, obsessive compulsive disorder, headaches, and chronic pain disorders.
Read More